Risk of COVID-19 in patients treated for cancer: an immune response-based hypothesis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Despite a considerable increase of new coronavirus (SARS-CoV-2) related publications, there are still few data to quantify the risk of infection in patients under treatment for cancer. Reports from the epicenter of the viral epidemic show in cancer patients a risk of infection and a mortality rate of about 2% and 4% respectively.(...)
European Journal of Cancer , éditorial en libre accès, 2019